Source: International Journal of Stroke. Unidades: HU, FM, IME
Subjects: PAÍSES EM DESENVOLVIMENTO, ACIDENTE VASCULAR CEREBRAL, NEUROLOGIA, FATORES DE RISCO, ESTATÍSTICA APLICADA
ABNT
GOULART, Alessandra Carvalho et al. The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA). International Journal of Stroke, v. 17, n. 1, p. 48-58, 2022Tradução . . Disponível em: https://doi.org/10.1177/1747493021995592. Acesso em: 17 ago. 2024.APA
Goulart, A. C., Olmos, R. D., Santos, I. S., Tunes, G., Alencar, A. P., Thomas, G. N., et al. (2022). The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA). International Journal of Stroke, 17( 1), 48-58. doi:10.1177/1747493021995592NLM
Goulart AC, Olmos RD, Santos IS, Tunes G, Alencar AP, Thomas GN, Lip G, Lotufo PA, Bensenor IJM. The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA) [Internet]. International Journal of Stroke. 2022 ; 17( 1): 48-58.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1177/1747493021995592Vancouver
Goulart AC, Olmos RD, Santos IS, Tunes G, Alencar AP, Thomas GN, Lip G, Lotufo PA, Bensenor IJM. The impact of atrial fibrillation and long-term oral anticoagulant use on all-cause and cardiovascular mortality: A 12-year evaluation of the prospective Brazilian Study of Stroke Mortality and Morbidity (EMMA) [Internet]. International Journal of Stroke. 2022 ; 17( 1): 48-58.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1177/1747493021995592